Table 2 Treatment characteristics for 33 extramedullary plasmocytoma lesions
From: Impact of radiation dose on local control and survival in extramedullary head and neck plasmacytoma
Characteristic | Value | Percentage/range |
|---|---|---|
Treatment parameters | ||
Med. radiation dose (range), Gy | 45 | 12–55.8 |
≤ 45 Gy | 18/33 | 55% |
> 45 Gy | 15/33 | 45% |
Med. fraction dose (range), Gy | 2 | 1.8–4.0 |
Med. treatment time, d | 35 | 4–52 |
Sites of RT | ||
Nasal/paranasal | 10/33 | 30% |
Pharynx | 6/33 | 18% |
Orbital/epidural | 6/33 | 18% |
Cervical | 6/33 | 18% |
Cutaneous/muscular | 5/33 | 16% |
Type of RT | ||
Postoperative | 11/33 | 33% |
Definitive | 22/33 | 67% |
RT technique | ||
IMRT | 14/33 | 42% |
CRT | 19/33 | 58% |
Bone erosion | ||
Yes | 13/33 | 40% |
No | 14/33 | 42% |
Unknown | 16/33 | 18% |
Local response | ||
Complete response | 14/33 | 43% |
Partial response | 11/33 | 33% |
Stable | 1/33 | 3% |
Progression | 3/33 | 6% |
Unknow | 5/33 | 15% |